{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T14:30:01Z","timestamp":1771943401080,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.endinu.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T17:48:23Z","timestamp":1489686503000},"page":"276-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ectopic Cushing's syndrome: Paradoxical effect of somatostatin analogs"],"prefix":"10.1016","volume":"64","author":[{"given":"Betina","family":"Biagetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Sim\u00f3-Servat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Ortiz-Z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.endinu.2017.01.004_bib0055","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.endinu.2017.01.004_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.endinu.2017.01.004_bib0065","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1002\/cncr.26029","article-title":"Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience","volume":"117","author":"Ejaz","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.endinu.2017.01.004_bib0070","first-page":"20","article-title":"Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor","volume":"78","author":"Phlipponneau","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"10.1016\/j.endinu.2017.01.004_bib0075","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJM200506093522322","article-title":"Cabergoline plus lanreotide for ectopic Cushing's syndrome","volume":"352","author":"Pivonello","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.endinu.2017.01.004_bib0080","first-page":"549","article-title":"Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease","volume":"28","author":"Su\u00e1rez-Llanos","year":"2007","journal-title":"Neuro Endocrinol Lett"},{"issue":"5\u20136","key":"10.1016\/j.endinu.2017.01.004_bib0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000182737","article-title":"Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma","volume":"39","author":"Rieu","year":"1993","journal-title":"Horm Res"},{"issue":"9","key":"10.1016\/j.endinu.2017.01.004_bib0090","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.endinu.2017.01.004_bib0095","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1152\/ajpendo.00004.2005","article-title":"Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells","volume":"289","author":"van der Hoek","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.endinu.2017.01.004_bib0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2011-1264","article-title":"Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion","volume":"97","author":"de Bruin","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417300460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417300460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T22:52:07Z","timestamp":1636239127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016417300460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2530016417300460"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2017.01.004","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectopic Cushing's syndrome: Paradoxical effect of somatostatin analogs","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEEN. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}